Significance of Midkine Signaling in Women’s Cancers: Novel Biomarker and Therapeutic Target is a research paper published in International Journal of Molecular Sciences (2025). On theSindex it has a DataRank of 0. It has been cited 13 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
STX-MSTP–NIH
Grant: T32GM113896
STX-MSTP–NIH
Grant: T32GM145432
STX-MSTP–NIH
Grant: NIH-R01CA267893
STX-MSTP–NIH
Grant: NIH R01 CA266970-01A1
STX-MSTP–NIH
Grant: VA1 I01 BX006280-02
National Institutes of Health
Grant: 5R01CA266970-02
Novel targeted therapy for treating Ovarian Cancer
National Institutes of Health
Grant: 3T32GM113896-03S1
South Texas Medical Scientist Training Program (STX-MSTP)
National Institutes of Health
Grant: 5T32GM145432-03
South Texas Medical Scientist Training Program (STX-MSTP)
National Institutes of Health
Grant: 4R01CA267893-04
Development of new therapeutic approaches for endometrial cancer
Fields of Study
Keywords